Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Antiviral Chemistry & Chemotherapy|April 13, 2004
Challenges for the development of ribonucleoside analogues as inducers of error catastropheJason D Graci, Craig E Cameron
Future Virology|September 4, 2009
Therapeutically targeting RNA viruses via lethal mutagenesisJason D Graci, Craig E Cameron
Virology|July 20, 2002
Quasispecies, error catastrophe, and the antiviral activity of ribavirinJason D Graci, Craig E Cameron
Reviews in Medical Virology|November 16, 2005
Mechanisms of action of ribavirin against distinct virusesJason D Graci, Craig E Cameron
Antiviral Chemistry & Chemotherapy|June 2, 2009
HIV type-1 latency: targeted induction of proviral reservoirsJason D Graci, Joseph M Colacino, Stuart W Peltz, et al.
Journal of Virology|December 23, 2011
Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesisJason D Graci, Nina F Gnädig, Jessica E Galarraga, et al.
Journal of Medicinal Chemistry|December 11, 2007
Effects of introduction of hydrophobic group on ribavirin base on mutation induction and anti-RNA viral activityKei Moriyama, Tetsuya Suzuki, Kazuo Negishi, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2016
PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined ExperimentallyJason D Graci, Stephen P Jung, John Pichardo, et al.
Journal of Medicinal Chemistry|October 13, 2006
Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerasesDaniel A Harki, Jason D Graci, Jessica E Galarraga, et al.
Pageof 3